- CBD company Nova Botanix has received a warning from the FDA regarding their product claims and the coronavirus.
- The FDA cited multiple statements from the company’s website that violated regulations.
- Nova Botanix has 48 hours to provide proof of their compliance.
Nova Botanix LTD, a CBD company based out of London, recently received a warning letter from the U.S. Food and Drug Administration regarding false claims about their product and the coronavirus.
Their CBD products, which are branded as CanaBD, were holding claims that it could prevent or treat COVID-19 infections. The FDA sent out the letter on Thursday and added Nova Botanix to the growing list of companies receiving warning letters from the FDA.
Even though the company is located in the UK, their products are available to purchase online for U.S. citizens. Due to this fact, the FDA had the authority to send them a warning because their claims violated regulations within the U.S.
The FDA has cited various statements found on the CanaBD website that warranted the letter, including:
- “Finding relief from an incurable virus is just within reach in the form of CBD oil.”
- “CBD oil has also been proven to offer relief to some of the symptoms.”
- “CBD oil may help to prevent getting infected by strengthening your immune system.”
The letter states that the company has 48 hours to respond and inform the agency what actions have been taken to correct the violations. If they do not respond, they risk legal action being taken against them.
Nova Botanix has yet to offer a comment on the situation
Kyle Turley, a former offensive tackle in the NFL, was also recently issued a warning letter from the FDA regarding his claims about his CBD products. Much like with CanaBD, the FDA is making it clear that they are “taking urgent measures to protect consumers from certain products that, without approval or authorization by the FDA, claim to mitigate, prevent, treat, diagnose or cure COVID-19 in people.”
A big thank you goes out to the FDA for having the backs of consumers everywhere.